BRIOBACEPT
UNII 993AP24910

Substance Identification & Data

This profile provides standardized clinical and technical data for Briobacept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 993AP24910.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 869881-54-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
993AP24910
CAS Registry Number
869881-54-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRIOBACEPT
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8963
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
SS-79
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Briobacept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRIOBACEPT

Common Names & Synonyms

BRIOBACEPT [INN]
BRIOBACEPT [USAN]
BRIOBACEPT [WHO-DD]
CYTOKINE RECEPTOR BAFF-R (HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT BR3) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN FC DOMAIN-CONTAINING FRAGMENT), DIMER

Technical Codes

BR-3-FC
SS-79